Cargando…

Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients

OBJECTIVE—A lower in vivo mitochondrial function has been reported in both type 2 diabetic patients and first-degree relatives of type 2 diabetic patients. The nature of this reduction is unknown. Here, we tested the hypothesis that a lower intrinsic mitochondrial respiratory capacity may underlie l...

Descripción completa

Detalles Bibliográficos
Autores principales: Phielix, Esther, Schrauwen-Hinderling, Vera B., Mensink, Marco, Lenaers, Ellen, Meex, Ruth, Hoeks, Joris, Kooi, Marianne Eline, Moonen-Kornips, Esther, Sels, Jean-Pierre, Hesselink, Matthijs K.C., Schrauwen, Patrick
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570390/
https://www.ncbi.nlm.nih.gov/pubmed/18678616
http://dx.doi.org/10.2337/db08-0391
_version_ 1782160120883445760
author Phielix, Esther
Schrauwen-Hinderling, Vera B.
Mensink, Marco
Lenaers, Ellen
Meex, Ruth
Hoeks, Joris
Kooi, Marianne Eline
Moonen-Kornips, Esther
Sels, Jean-Pierre
Hesselink, Matthijs K.C.
Schrauwen, Patrick
author_facet Phielix, Esther
Schrauwen-Hinderling, Vera B.
Mensink, Marco
Lenaers, Ellen
Meex, Ruth
Hoeks, Joris
Kooi, Marianne Eline
Moonen-Kornips, Esther
Sels, Jean-Pierre
Hesselink, Matthijs K.C.
Schrauwen, Patrick
author_sort Phielix, Esther
collection PubMed
description OBJECTIVE—A lower in vivo mitochondrial function has been reported in both type 2 diabetic patients and first-degree relatives of type 2 diabetic patients. The nature of this reduction is unknown. Here, we tested the hypothesis that a lower intrinsic mitochondrial respiratory capacity may underlie lower in vivo mitochondrial function observed in diabetic patients. RESEARCH DESIGN AND METHODS—Ten overweight diabetic patients, 12 first-degree relatives, and 16 control subjects, all men, matched for age and BMI, participated in this study. Insulin sensitivity was measured with a hyperinsulinemic-euglycemic clamp. Ex vivo intrinsic mitochondrial respiratory capacity was determined in permeabilized skinned muscle fibers using high-resolution respirometry and normalized for mitochondrial content. In vivo mitochondrial function was determined by measuring phosphocreatine recovery half-time after exercise using (31)P-magnetic resonance spectroscopy. RESULTS—Insulin-stimulated glucose disposal was lower in diabetic patients compared with control subjects (11.2 ± 2.8 vs. 28.9 ± 3.7 μmol · kg(−1) fat-free mass · min(−1), respectively; P = 0.003), with intermediate values for first-degree relatives (22.1 ± 3.4 μmol · kg(−1) fat-free mass · min(−1)). In vivo mitochondrial function was 25% lower in diabetic patients (P = 0.034) and 23% lower in first-degree relatives, but the latter did not reach statistical significance (P = 0.08). Interestingly, ADP-stimulated basal respiration was 35% lower in diabetic patients (P = 0.031), and fluoro-carbonyl cyanide phenylhydrazone–driven maximal mitochondrial respiratory capacity was 31% lower in diabetic patients (P = 0.05) compared with control subjects with intermediate values for first-degree relatives. CONCLUSIONS—A reduced basal ADP-stimulated and maximal mitochondrial respiratory capacity underlies the reduction in in vivo mitochondrial function, independent of mitochondrial content. A reduced capacity at both the level of the electron transport chain and phosphorylation system underlies this impaired mitochondrial capacity.
format Text
id pubmed-2570390
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-25703902009-11-01 Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients Phielix, Esther Schrauwen-Hinderling, Vera B. Mensink, Marco Lenaers, Ellen Meex, Ruth Hoeks, Joris Kooi, Marianne Eline Moonen-Kornips, Esther Sels, Jean-Pierre Hesselink, Matthijs K.C. Schrauwen, Patrick Diabetes Metabolism OBJECTIVE—A lower in vivo mitochondrial function has been reported in both type 2 diabetic patients and first-degree relatives of type 2 diabetic patients. The nature of this reduction is unknown. Here, we tested the hypothesis that a lower intrinsic mitochondrial respiratory capacity may underlie lower in vivo mitochondrial function observed in diabetic patients. RESEARCH DESIGN AND METHODS—Ten overweight diabetic patients, 12 first-degree relatives, and 16 control subjects, all men, matched for age and BMI, participated in this study. Insulin sensitivity was measured with a hyperinsulinemic-euglycemic clamp. Ex vivo intrinsic mitochondrial respiratory capacity was determined in permeabilized skinned muscle fibers using high-resolution respirometry and normalized for mitochondrial content. In vivo mitochondrial function was determined by measuring phosphocreatine recovery half-time after exercise using (31)P-magnetic resonance spectroscopy. RESULTS—Insulin-stimulated glucose disposal was lower in diabetic patients compared with control subjects (11.2 ± 2.8 vs. 28.9 ± 3.7 μmol · kg(−1) fat-free mass · min(−1), respectively; P = 0.003), with intermediate values for first-degree relatives (22.1 ± 3.4 μmol · kg(−1) fat-free mass · min(−1)). In vivo mitochondrial function was 25% lower in diabetic patients (P = 0.034) and 23% lower in first-degree relatives, but the latter did not reach statistical significance (P = 0.08). Interestingly, ADP-stimulated basal respiration was 35% lower in diabetic patients (P = 0.031), and fluoro-carbonyl cyanide phenylhydrazone–driven maximal mitochondrial respiratory capacity was 31% lower in diabetic patients (P = 0.05) compared with control subjects with intermediate values for first-degree relatives. CONCLUSIONS—A reduced basal ADP-stimulated and maximal mitochondrial respiratory capacity underlies the reduction in in vivo mitochondrial function, independent of mitochondrial content. A reduced capacity at both the level of the electron transport chain and phosphorylation system underlies this impaired mitochondrial capacity. American Diabetes Association 2008-11 /pmc/articles/PMC2570390/ /pubmed/18678616 http://dx.doi.org/10.2337/db08-0391 Text en Copyright © 2008, American Diabetes Association Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Metabolism
Phielix, Esther
Schrauwen-Hinderling, Vera B.
Mensink, Marco
Lenaers, Ellen
Meex, Ruth
Hoeks, Joris
Kooi, Marianne Eline
Moonen-Kornips, Esther
Sels, Jean-Pierre
Hesselink, Matthijs K.C.
Schrauwen, Patrick
Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients
title Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients
title_full Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients
title_fullStr Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients
title_full_unstemmed Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients
title_short Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients
title_sort lower intrinsic adp-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients
topic Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570390/
https://www.ncbi.nlm.nih.gov/pubmed/18678616
http://dx.doi.org/10.2337/db08-0391
work_keys_str_mv AT phielixesther lowerintrinsicadpstimulatedmitochondrialrespirationunderliesinvivomitochondrialdysfunctioninmuscleofmaletype2diabeticpatients
AT schrauwenhinderlingverab lowerintrinsicadpstimulatedmitochondrialrespirationunderliesinvivomitochondrialdysfunctioninmuscleofmaletype2diabeticpatients
AT mensinkmarco lowerintrinsicadpstimulatedmitochondrialrespirationunderliesinvivomitochondrialdysfunctioninmuscleofmaletype2diabeticpatients
AT lenaersellen lowerintrinsicadpstimulatedmitochondrialrespirationunderliesinvivomitochondrialdysfunctioninmuscleofmaletype2diabeticpatients
AT meexruth lowerintrinsicadpstimulatedmitochondrialrespirationunderliesinvivomitochondrialdysfunctioninmuscleofmaletype2diabeticpatients
AT hoeksjoris lowerintrinsicadpstimulatedmitochondrialrespirationunderliesinvivomitochondrialdysfunctioninmuscleofmaletype2diabeticpatients
AT kooimarianneeline lowerintrinsicadpstimulatedmitochondrialrespirationunderliesinvivomitochondrialdysfunctioninmuscleofmaletype2diabeticpatients
AT moonenkornipsesther lowerintrinsicadpstimulatedmitochondrialrespirationunderliesinvivomitochondrialdysfunctioninmuscleofmaletype2diabeticpatients
AT selsjeanpierre lowerintrinsicadpstimulatedmitochondrialrespirationunderliesinvivomitochondrialdysfunctioninmuscleofmaletype2diabeticpatients
AT hesselinkmatthijskc lowerintrinsicadpstimulatedmitochondrialrespirationunderliesinvivomitochondrialdysfunctioninmuscleofmaletype2diabeticpatients
AT schrauwenpatrick lowerintrinsicadpstimulatedmitochondrialrespirationunderliesinvivomitochondrialdysfunctioninmuscleofmaletype2diabeticpatients